BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, January 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2021
View Archived Issues
Alethia studies AB-16B5 with docetaxel in phase II for metastatic NSCLC
Read More
Beth Israel Deaconess Medical Center presents anti-Tn antibodies
Read More
Janssen R&D Ireland divulges new antituberculous compounds
Read More
ER-alpha antagonists and SERDs patented by Sanofi
Read More
Bayer discovers BCAT1/2 ihibitors
Read More
HBV HBeAg and HBsAg secretion inhibitors identified at Roche
Read More
Acylaminooxadiazoles inhibit trans-translation and show in vivo efficacy against N. gonorrhoeae
Read More
A new knock-in mouse model related to spinocerebellar ataxia 14
Read More
Harpoon Therapeutics develops FLT3-targeting TriTACs for treating acute myeloid leukemia
Read More
CD161 linked to outcomes in head and neck cancer patients
Read More
NX-1607 targets E3 ubiquitin-protein ligase CBL-B for antitumor immunotherapy
Read More
Aurigene details preclinical activity of anticancer compounds AU-18069 and AU-19820
Read More
Soticlestat reduces frequency of seizures in pediatric patients with DS and LGS
Read More
Autophagy chaperone targets aggregation-prone proteins
Read More
FDA removes clinical hold on IND application for VY-HTT01
Read More
Promising phase II data presented for olamkicept in ulcerative colitis
Read More
First patient enrolled in phase IIa study of CM-101 in NASH
Read More
Roflumilast demonstrates cognition-enhancing effects in patients with schizophrenia
Read More
Reviva reports strong phase II data in schizophrenia
Read More
Neoleukin to proceed with phase I study of NL-201 in the U.S.
Read More
FDA removes clinical hold on uniQure's hemophilia B gene therapy program
Read More
Cybin targets IND filing for CYB-003 for alcohol use disorder by year-end
Read More
CoA Therapeutics initiates phase I study of BBP-671
Read More
FYB-207 advancing towards clinical trials for COVID-19 in fourth quarter
Read More
SciClone evaluates COVID-19 inactivated vaccine with Zadaxin in China
Read More
